DIMENSIONAL FUND ADVISORS LP

Holdings History for Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN)

Symbol: LTRN on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$118,503	39,110	-1,034	-2.6%	$3.03	Q4 2025
30 Sep 2025	0%	-0%	$174,626	40,144	-796	-1.9%	$4.35	Q3 2025
30 Jun 2025	0%	+0%	$129,370	40,940	+3,457	+9.2%	$3.16	Q2 2025
31 Mar 2025	0%	+0%	$132,690	37,483	+934		$3.54	Q1 2025
31 Dec 2024	0%	-0%	$116,592	36,549	-999	-2.7%	$3.19	Q4 2024
30 Sep 2024	0%	+0%	$137,802	37,548	+19,135	+104%	$3.67	Q3 2024
30 Jun 2024	0%	+0%	$85,989	18,413	+6,585	+56%	$4.67	Q2 2024
31 Mar 2024	0%	0%	$104,086	11,828	0		$8.80	Q1 2024
31 Dec 2023	0%	+0%	$50,624	11,828	+11,828	NEW	$4.28	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.